Stanton Goldman
Pediatric Hematology-Oncology · Dallas, TXNPI 1295778843
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $202,150 of the $233,866 with a category attached, or 86.4%. Jazz Pharmaceuticals Inc. accounts for 99.4% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $84,531 and has fallen 70.2% since, to $25,188 in 2025. Among pediatric hematology-oncology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 250 payments — averaging $935.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$232K
- Sanofi$318
- Sobi, Inc$239
- Astellas Pharma US Inc$208
- Servier Pharmaceuticals LLC$187
- Genentech, Inc.$150
- plus $284 from 8 others
Across 49 payments — averaging $8240.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$386K
- Bioverativ Therapeutics Inc.$13K
- Incyte Corporation$4K
- E.r. Squibb & Sons, L.L.C.$1K
What the payments were for
- Consulting fees$3,1801%
- Speaking & faculty fees$202,15086%
- Travel & lodging$22,86110%
- Food & beverage$5,4172%
- Education$2580%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 217 | $232,480 |
| Sanofi | 5 | $318 |
| Sobi, Inc | 3 | $239 |
| Astellas Pharma US Inc | 7 | $208 |
| Servier Pharmaceuticals LLC | 2 | $187 |
| Genentech, Inc. | 3 | $150 |
| Pfizer | 5 | $99 |
| AstraZeneca | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $26 |
| Genentech USA, Inc. | 1 | $25 |
| Merck | 1 | $23 |
| USWM, LLC | 1 | $22 |
| Fennec Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$233,866 in reported general payments places this provider in the 95th percentile of 235 pediatric hematology-oncology providers in Texas.
Other pediatric hematology-oncology in Dallas
- Maurizio GhisoliDallas$174K
- Joel WeinthalDallas$161K
- Ayesha ZiaDallas$74K
- Jessica GarciaDallas$68K
- Matthew FletcherDallas$40K
- Janna JourneycakeDallas$19K
- Zora RogersDallas$15K
- Kathryn DickersonDallas$10K
- Laura KlesseDallas$9K
- Tanya WattDallas$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.